MedPath

Glycerol phenylbutyrate

Generic Name
Glycerol phenylbutyrate
Brand Names
Ravicti
Drug Type
Small Molecule
Chemical Formula
C33H38O6
CAS Number
611168-24-2
Unique Ingredient Identifier
ZH6F1VCV7B

Overview

Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.

Background

Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.

Indication

Glycerol phenylbutyrate is a nitrogen-binding agent for the chronic management of adult and pediatric patients ≥2 years of age with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.

Associated Conditions

  • Disorders of urea cycle metabolism

FDA Approved Products

Ravicti
Manufacturer:Horizon Therapeutics USA, Inc.
Route:ORAL
Strength:1.1 g in 1 mL
Approved: 2021/09/13
NDC:75987-050

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath